Top Markets
#1 Black Phoenix Black Phoenix +365.41%
#2 Islamic Coin Islamic Coin +158.18%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.04%
#5 Akedo Akedo +35.88%
#6 Acurast Acurast +28.33%
#7 BasedHype BasedHype +27.99%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.34%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +20.60%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rang in aandelen #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Aandeelprijs
$0.0003
Laatst gesynchroniseerd: 2023-06-13
Marktkapitalisatie
$28.14K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Neuropathix, Inc. (NPTX)

Categorie

Healthcare
P/B-ratio voor Neuropathix, Inc. (NPTX)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Neuropathix, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Neuropathix, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE